Literature DB >> 24440448

Evolutionary aspects of cancer resistance.

George Klein1.   

Abstract

Humans are relatively cancer resistant, as judged by the absence of cancer in two thirds of the population. The susceptibility/resistance of other mammalians varies but shows no relationship to body size. Selection for longevity and cancer resistance may occur in parallel, as indicated by the extremely long lived and cancer free mole rat species. Microenvironmental control may play a major role in the defense against potential neoplastic cells. Our work confirms that normal fibroblasts inhibit the growth of tumor cells in vitro, largely by a contact dependent mechanism. The inhibitory capacity of the fibroblast differs depending on the site of origin, and is also different between normal and cancer derived stroma cells. Preliminary gene analysis points to major differences in gene expression in between inhibitory and non-inhibitory fibroblasts.
Copyright © 2014. Published by Elsevier Ltd.

Entities:  

Keywords:  Cancer resistance; Fibroblasts; Microenvironment; Neighbor suppression

Mesh:

Year:  2014        PMID: 24440448     DOI: 10.1016/j.semcancer.2014.01.001

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  14 in total

1.  Higher levels of antibodies to the tumour-associated antigen cyclin B1 in cancer-free individuals than in patients with breast cancer.

Authors:  J P Pandey; E Kistner-Griffin; A M Namboodiri; M Iwasaki; Y Kasuga; G S Hamada; S Tsugane
Journal:  Clin Exp Immunol       Date:  2014-10       Impact factor: 4.330

2.  Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma.

Authors:  Andrew D Rhim; Paul E Oberstein; Dafydd H Thomas; Emily T Mirek; Carmine F Palermo; Stephen A Sastra; Erin N Dekleva; Tyler Saunders; Claudia P Becerra; Ian W Tattersall; C Benedikt Westphalen; Jan Kitajewski; Maite G Fernandez-Barrena; Martin E Fernandez-Zapico; Christine Iacobuzio-Donahue; Kenneth P Olive; Ben Z Stanger
Journal:  Cancer Cell       Date:  2014-05-22       Impact factor: 31.743

Review 3.  Subversion of host genome integrity by bacterial pathogens.

Authors:  Cindrilla Chumduri; Rajendra Kumar Gurumurthy; Rike Zietlow; Thomas F Meyer
Journal:  Nat Rev Mol Cell Biol       Date:  2016-08-18       Impact factor: 94.444

Review 4.  Potential role of cancer stem cells as biomarkers and therapeutic targets in cervical cancer.

Authors:  Niyati Sudhalkar; Nidul P Rathod; Ashwathi Mathews; Supriya Chopra; Harshini Sriram; Shyam K Shrivastava; Jayant S Goda
Journal:  Cancer Rep (Hoboken)       Date:  2018-11-08

5.  IGHG, IGKC, and FCGR genes and endogenous antibody responses to GARP in patients with breast cancer and matched controls.

Authors:  Janardan P Pandey; Aryan M Namboodiri; Kent E Armeson; Motoki Iwasaki; Yoshio Kasuga; Gerson S Hamada; Shoichiro Tsugane
Journal:  Hum Immunol       Date:  2018-06-04       Impact factor: 2.850

6.  Endogenous antibody responses to mucin 1 in a large multiethnic cohort of patients with breast cancer and healthy controls: Role of immunoglobulin and Fcγ receptor genes.

Authors:  Janardan P Pandey; Aryan M Namboodiri; Bethany Wolf; Motoki Iwasaki; Yoshio Kasuga; Gerson S Hamada; Shoichiro Tsugane
Journal:  Immunobiology       Date:  2017-10-18       Impact factor: 3.144

Review 7.  Do anti-stroma therapies improve extrinsic resistance to increase the efficacy of gemcitabine in pancreatic cancer?

Authors:  Chen Liang; Si Shi; Qingcai Meng; Dingkong Liang; Shunrong Ji; Bo Zhang; Yi Qin; Jin Xu; Quanxing Ni; Xianjun Yu
Journal:  Cell Mol Life Sci       Date:  2017-10-09       Impact factor: 9.261

8.  Tumor-associated fibroblasts predominantly come from local and not circulating precursors.

Authors:  Ainhoa Arina; Christian Idel; Elizabeth M Hyjek; Maria-Luisa Alegre; Ying Wang; Vytautas P Bindokas; Ralph R Weichselbaum; Hans Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-17       Impact factor: 11.205

Review 9.  Hyaluronan, Cancer-Associated Fibroblasts and the Tumor Microenvironment in Malignant Progression.

Authors:  James B McCarthy; Dorraya El-Ashry; Eva A Turley
Journal:  Front Cell Dev Biol       Date:  2018-05-08

Review 10.  Ion Channel Profiling in Prostate Cancer: Toward Cell Population-Specific Screening.

Authors:  Valerio Farfariello; Natalia Prevarskaya; Dimitra Gkika
Journal:  Rev Physiol Biochem Pharmacol       Date:  2021       Impact factor: 5.545

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.